Lung transplantation: challenges in the COVID-19 era, a review of the literature

: The severe acute respiratory syndrome coronavirus 2 pandemic poses unique challenges for lung transplant recipients. optimal management of these patients is not known and the risk transmission SARS-CoV-2 during transplantation a major concern. Clear guidelines selection candidates due to chronic pulmonary disease COVID-19 are urgently needed. objective this study review available evidence on diagnosis treatment 2019 in recipients, as well current recommendations regarding screening potential organ donors recipients implementation vaccine both waitlist after transplantation. We performed an electronic search literature PubMed, MedRxiv SARS-Cov-2, LitCovid-NCBI-NLM-NIH, Medline databases, From December January 22, 2021. following keywords with without Boolean operators were used: “covid-19”, “SARS-CoV-2” combination “lung transplantation”, “solid transplant”, “immunosuppression”. Articles English Spanish languages extracted. Web sites Center Disease Control (CDC), International Society Heart & Lung Transplantation, National Institute Health, Infectious Diseases America (IDSA), Federal Drug Administration reviewed. A total 168 reports websites references used review. at increased illness death. Management should be similar general population but immunosuppression must adjusted. receive 3 months Extreme care taken precent number post failure referred expected increase near future. There much COVID-19. Protocols needed prevent clear define criteria residual infection.